This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Luigi Manenti: Innovator in Cancer Treatment
Introduction
Luigi Manenti is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work has led to the development of a unique combination of therapies aimed at improving patient outcomes.
Latest Patents
Luigi Manenti holds a patent for "Combinations of FGFR4 inhibitors and bile acid sequestrants." This invention relates to a pharmaceutical combination that includes an FGFR4 inhibitor and a bile acid sequestrant. The patent outlines the use of this combination in the treatment of cancer and highlights the role of bile acid sequestrants in reducing or mitigating side effects associated with FGFR4 inhibition therapy.
Career Highlights
Luigi Manenti is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key player in the fight against cancer.
Collaborations
Luigi collaborates with esteemed colleagues, including Robin Alec Fairhurst and Diana Graus Porta. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.
Conclusion
Luigi Manenti's contributions to cancer treatment through his patented inventions exemplify the impact of innovative thinking in the pharmaceutical industry. His work continues to inspire advancements in medical therapies that aim to improve patient care.